Infants with Congenital Diseases Identified through Newborn Screening—United States, 2018–2020
Newborn screening (NBS) is a state or territory-based public health system that screens newborns for congenital diseases that typically do not present with clinical symptoms at birth but can cause significant mortality and morbidity if not detected or treated quickly. NBS continues to be one of the...
Main Authors: | Amy Gaviglio, Sarah McKasson, Sikha Singh, Jelili Ojodu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | International Journal of Neonatal Screening |
Subjects: | |
Online Access: | https://www.mdpi.com/2409-515X/9/2/23 |
Similar Items
-
Expanding Newborn Screening for Pompe Disease in the United States: The NewSTEPs New Disorders Implementation Project, a Resource for New Disorder Implementation
by: Kshea Hale, et al.
Published: (2020-06-01) -
Landscape of Spinal Muscular Atrophy Newborn Screening in the United States: 2018–2021
by: Kshea Hale, et al.
Published: (2021-06-01) -
Development of National Newborn Screening Quality Indicators in the United States
by: Careema Yusuf, et al.
Published: (2019-09-01) -
Implementing Statewide Newborn Screening for New Disorders: U.S. Program Experiences
by: Yvonne Kellar-Guenther, et al.
Published: (2020-04-01) -
Implementation of Newborn Screening for Conditions in the United States First Recommended during 2010–2018
by: Sikha Singh, et al.
Published: (2023-04-01)